Robert E. Landry
Overview
Robert E. Landry received an average of $8M in total compensation, including $603K in salary, at Regeneron Pharmaceuticals from 2013 to 2021.
2021Regeneron PharmaceuticalsExecutive Vice President, Finance and Chief Financial Officer
2020Regeneron PharmaceuticalsExecutive Vice President, Finance and Chief Financial Officer
2019Regeneron PharmaceuticalsExecutive Vice President, Finance and Chief Financial Officer
2018Regeneron PharmaceuticalsSenior Vice President, Finance and Chief Financial Officer
2017Regeneron PharmaceuticalsSenior Vice President, Finance and Chief Financial Officer
2016Regeneron PharmaceuticalsSenior Vice President, Finance and Chief Financial Officer
2015Regeneron PharmaceuticalsSenior Vice President, Finance and Chief Financial Officer
2014Regeneron PharmaceuticalsSenior Vice President, Finance and Chief Financial Officer
2013Regeneron PharmaceuticalsSenior Vice President, Finance and Chief Financial Officer
Source: SEC filings on April 21, 2022, April 23, 2021, April 24, 2020, April 26, 2019, and April 26, 2016.
Related executives
We found ten more executives who work or worked at Regeneron Pharmaceuticals.
Daniel Van Plew
Regeneron Pharmaceuticals
Executive Vice President and General Manager, Industrial Operations and Product Supply
Andrew Murphy
Regeneron Pharmaceuticals
Executive Vice President, Research
Joseph LaRosa
Regeneron Pharmaceuticals
General Counsel
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
George Yancopoulos
Regeneron Pharmaceuticals
Chief Scientific Officer
Marion McCourt
Regeneron Pharmaceuticals
Senior Vice President, Commercial
Neil Stahl
Regeneron Pharmaceuticals
Executive Vice President, Research & Development
Robert Terifay
Regeneron Pharmaceuticals
Executive Vice President, Commercial
News
Regeneron Pharmaceuticals Executive Vice President and General Manager, Industrial Operations and Product Supply Daniel Van Plew's 2021 pay rises 1% to $8.8M
April 21, 2022
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2020 pay jumps 531% to $135M
April 23, 2021
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2019 pay slips 19% to $21M
April 24, 2020
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2018 pay stays at $27M
April 26, 2019